JP2000505469A5 - - Google Patents

Download PDF

Info

Publication number
JP2000505469A5
JP2000505469A5 JP1997530671A JP53067197A JP2000505469A5 JP 2000505469 A5 JP2000505469 A5 JP 2000505469A5 JP 1997530671 A JP1997530671 A JP 1997530671A JP 53067197 A JP53067197 A JP 53067197A JP 2000505469 A5 JP2000505469 A5 JP 2000505469A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997530671A
Other languages
English (en)
Japanese (ja)
Other versions
JP2000505469A (ja
JP4102440B2 (ja
Filing date
Publication date
Priority claimed from FR9602472A external-priority patent/FR2745290B1/fr
Application filed filed Critical
Publication of JP2000505469A publication Critical patent/JP2000505469A/ja
Publication of JP2000505469A5 publication Critical patent/JP2000505469A5/ja
Application granted granted Critical
Publication of JP4102440B2 publication Critical patent/JP4102440B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP53067197A 1996-02-28 1997-02-27 新規なエリスロマイシン誘導体、それらの調製方法及びそれらの医薬品としての使用 Expired - Lifetime JP4102440B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR96/02472 1996-02-28
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1997/000351 WO1997031929A1 (fr) 1996-02-28 1997-02-27 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (3)

Publication Number Publication Date
JP2000505469A JP2000505469A (ja) 2000-05-09
JP2000505469A5 true JP2000505469A5 (enExample) 2004-11-25
JP4102440B2 JP4102440B2 (ja) 2008-06-18

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53067197A Expired - Lifetime JP4102440B2 (ja) 1996-02-28 1997-02-27 新規なエリスロマイシン誘導体、それらの調製方法及びそれらの医薬品としての使用

Country Status (31)

Country Link
US (1) US6096714A (enExample)
EP (1) EP0885234B1 (enExample)
JP (1) JP4102440B2 (enExample)
KR (1) KR100486053B1 (enExample)
CN (1) CN1168734C (enExample)
AP (1) AP952A (enExample)
AR (1) AR005999A1 (enExample)
AT (1) ATE217633T1 (enExample)
AU (1) AU716204B2 (enExample)
BG (1) BG63207B1 (enExample)
BR (1) BR9707709B1 (enExample)
CZ (1) CZ293893B6 (enExample)
DE (1) DE69712610T2 (enExample)
DK (1) DK0885234T3 (enExample)
EA (1) EA001376B1 (enExample)
EE (1) EE9800265A (enExample)
ES (1) ES2176698T3 (enExample)
FR (1) FR2745290B1 (enExample)
HU (1) HU227567B1 (enExample)
IL (1) IL125622A (enExample)
NO (1) NO983955D0 (enExample)
NZ (1) NZ331600A (enExample)
OA (1) OA10845A (enExample)
PL (1) PL191736B1 (enExample)
PT (1) PT885234E (enExample)
SK (1) SK118498A3 (enExample)
TR (1) TR199801713T2 (enExample)
UA (1) UA58504C2 (enExample)
WO (1) WO1997031929A1 (enExample)
YU (1) YU37098A (enExample)
ZA (1) ZA971659B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9649698A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
ZA989835B (en) * 1997-10-29 1999-05-05 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2781484B1 (fr) 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
TR200102128T2 (tr) 1999-01-27 2001-12-21 Pfizer Products Inc. Ketolid antibiyotikler
CZ20013733A3 (cs) * 1999-05-24 2002-11-13 Pfizer Products Inc. Deriváty 13-methylerythromycinu
AU6183800A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6183700A (en) * 1999-08-06 2001-03-05 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
WO2001010879A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
EP2772254A3 (en) 2003-03-10 2015-03-11 Optimer Pharmaceuticals, Inc. Novel Antibacterial Agents
WO2005007143A2 (en) * 2003-07-14 2005-01-27 The Board Of Trustees Of The University Of Illinois Use of makrolides and ketolides for the treatment of tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
JP5698979B2 (ja) * 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライド系抗菌剤の調製プロセス
EP2358379B1 (en) 2008-10-24 2015-12-16 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
AU2011232627B2 (en) 2010-03-22 2016-03-17 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
RU2608390C2 (ru) 2010-05-20 2017-01-18 Семпра Фармасьютикалз, Инк. Способы получения макролидов и кетолидов, и промежуточных соединений для их получения
WO2012034058A1 (en) 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
JP6208742B2 (ja) 2012-03-27 2017-10-04 センプラ ファーマシューティカルズ,インコーポレイテッド マクロライド抗生物質を投与するための非経口製剤
US9861616B2 (en) 2013-03-14 2018-01-09 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
US9751908B2 (en) 2013-03-15 2017-09-05 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of erythromycin derivatives
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Similar Documents

Publication Publication Date Title
JP2000502280A5 (enExample)
JP2000501771A5 (enExample)
JP2000501599A5 (enExample)
JP2001525822A5 (enExample)
JP2000501018A5 (enExample)
JP2000501324A5 (enExample)
JP2000500055A5 (enExample)
JP2000500026A5 (enExample)
JP2002512644A5 (enExample)
JP2000502472A5 (enExample)
JP2000501825A5 (enExample)
JP2000501338A5 (enExample)
JP2000500874A5 (enExample)
JP2000502485A5 (enExample)
JP2000502425A5 (enExample)
JP2000502568A5 (enExample)
JP2000501774A5 (enExample)
JP2000500912A5 (enExample)
JP2000502570A5 (enExample)
JP2000501876A5 (enExample)
JP2000501744A5 (enExample)
JP2000501229A5 (enExample)
JP2000502316A5 (enExample)
JP2000502714A5 (enExample)
JP2000501569A5 (enExample)